An In Vitro Model for Characterization of Drug Permeability across the Tympanic Membrane
Open Access
- 7 September 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (9) , 1114
Abstract
Otic disorders, such as otitis media and hearing loss, affect a substantial portion of the global population. Despite this, oto-therapeutics, in particular those intended to treat hearing loss, have seen limited development and innovation. A significant factor to this is likely a result of the inherent costs and complexities of drug discovery and development. With in vitro 3D tissue models seeing increased utility for the rapid, high-throughput screening of drug candidates, it stands to reason that the field of otology could greatly benefit from such innovations. In this study, we propose and describe an in vitro 3D model, designed using a physiologically based approach, which we suggest can be used to estimate drug permeability across human tympanic membranes (TM). We characterize the permeability properties of several template drugs in this model under various growth and storage conditions. The availability of such cost-effective, rapid, high-throughput screening tools should allow for increased innovation and the discovery of novel drug candidates over the currently used animal models. In the context of this TM permeation model, it may promote the development of topical drugs and formulations that can non-invasively traverse the TM and provide tissue-targeted drug delivery as an alternative to systemic treatment, an objective which has seen limited study until present.Keywords
Funding Information
- Office of Naval Research (N00014-20-1-2874)
This publication has 20 references indexed in Scilit:
- Dexamethasone and Dexamethasone Phosphate Entry into Perilymph Compared for Middle Ear Applications in Guinea PigsAudiology and Neurotology, 2018
- Chronic Ear DiseaseMedical Clinics of North America, 2018
- Treatment of Streptococcus pneumoniae otitis media in a chinchilla model by transtympanic delivery of antibioticsJCI Insight, 2018
- Getting Drugs Across Biological BarriersAdvanced Materials, 2017
- Current insights in noise-induced hearing loss: A literature review of the underlying mechanism, pathophysiology, asymmetry, and management optionsJournal of Otolaryngology - Head & Neck Surgery, 2017
- Treatment of otitis media by transtympanic delivery of antibioticsScience Translational Medicine, 2016
- Lipopolysaccharide-Induced Middle Ear Inflammation Disrupts the cochlear Intra-Strial Fluid–Blood Barrier through Down-Regulation of Tight Junction ProteinsPLOS ONE, 2015
- Determination of dexamethasone and dexamethasone sodium phosphate in human plasma and cochlear perilymph by liquid chromatography/tandem mass spectrometryJournal of Chromatography B, 2011
- The skin: an indispensable barrierExperimental Dermatology, 2008
- Transdermal drug deliveryNature Biotechnology, 2008